InnovAge Holding Corp.(INNV)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

InnovAge Holding Corp. (INNV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INNV at 55.0/100 on a 32-signal composite quality model, placing it at rank #1,281 of 2,962 stocks — the top half of the AI-ranked universe. INNV scores in the top quartile across earnings quality (97.4). Areas of concern include balance sheet strength (32.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), InnovAge Holding Corp. reports quarterly revenue of $262.0M, net income of $8.3M, an operating margin of 3.9%. Top institutional holders of INNV by reported 13-F value include T. Rowe Price Investment Management, FEDERATED HERMES, BlackRock, based on the most recent SEC filings. INNV trades on the Nasdaq exchange and files with the SEC under CIK 1834376. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INNV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InnovAge Holding Corp. directly from SEC EDGAR.

AI Quality Score

55.0/100

AI Rank

#1,281

Revenue

$262.0M

Net Income

$8.3M

Free Cash Flow

$17.0M

Operating Margin

3.9%

INNV key financials by period

InnovAge Holding Corp. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202610-K$989.7M$-2.5M0.3%
FY 202510-K$853.7M$-30.3M-3.5%
FY 202410-K$763.9M$-21.3M-3.0%
FY 202310-K$688.1M$-40.7M-7.2%
FY 202210-K$698.6M$-6.5M-0.6%
FY 202110-K$637.8M$-44.0M-1.9%

Institutions holding INNV

Institutional investors reporting a position in InnovAge Holding Corp. on SEC Form 13F.
InstitutionSharesValueReported
T. Rowe Price Investment Management6,124,069$72.6M2026-06-30
FEDERATED HERMES1,903,713$22.6M2026-06-30
BlackRock1,489,609$17.7M2026-06-30
VANGUARD CAPITAL MANAGEMENT935,264$11.1M2026-06-30
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP668,742$7.9M2026-06-30
ALGERT GLOBAL630,520$7.5M2026-06-30
GEODE CAPITAL MANAGEMENT602,127$7.1M2026-06-30
STATE STREET461,656$5.5M2026-06-30
DIMENSIONAL FUND ADVISORS439,962$5.2M2026-06-30
ACADIAN ASSET MANAGEMENT390,850$4.6M2026-06-30
INNV

InnovAge Holding Corp.

INNV
NasdaqSmall CapHealthcare

13F Pro Quality Score

55.0/100

Rank #1,281 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

68.8/100

Profitability

43.2/100

Balance Sheet

32.8/100

Earnings Quality

97.4/100

Free Cash Flow

42.7/100

Institutional Flow

45.6/100

Revenue Scale

49.6/100

Dilution Risk

66.8/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$261.95M

Net Income

Q2 2026
EDGAR

$8.29M

EPS (Diluted)

Q2 2026
EDGAR

$0.06

Operating Margin

Q2 2026
EDGAR

3.9%

ROIC

Q2 2026
EDGAR

14.1%

Free Cash Flow

Q2 2026
EDGAR

$17.02M

Debt/Equity

Q2 2026
EDGAR

0.22

Top Institutional Holders

as of Q2 2026
$217.48M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…